Sunday, May 10, 2020
The Problem Of A Growing World Population - 1939 Words
Global perspective: Countries with high average population density tend to be the same as those with large amounts of arable land (e.g. Canada has the 11th lowest population density and very little arable land at 4,73%) because large amounts of land are uninhabited. Generally, areas that are developing have higher population densities, however, less developed areas generally have more population growth. All solutions to the problem of a growing world population can be categorized into to categories - creating sustainable growth or keeping the population under control. The first way to create sustainable population growth is to raise education levels. Above are two graphs - the left one showing the HDI (Human Development Index - a comparative measure of life expectancy, literacy, education, standards of living and quality for life devised by the UN) of countries around the world and the right one showing the birth rates of countries around the world. The countries with the highest HDIs are shaded in green and the ones with the lowest are shaded in red, while the darker the color of a country, the higher its birth rate. From these two graphs one can see a definite correlation between having a high HDI and lower birth rates, leading to the fact that on average, educated people have fewer children than uneducated people. The reason many parents in poor regions of the Earth want many children is that they hope that at least one of the children will survive a cruelShow MoreRelatedThe World Population Is Evolving Ageing And Cognitive Impairment ( Ci ) Is A Fast Growing Problem1722 Words à |à 7 Pagesbecoming a more prevalent, frightening, and expensive personal and social problem ââ¬â but a problem that companies can more effectively address with innovative products and services. The world population is rapidly ageing and cognitive impairment (CI) is a fast growing problem Cognition is the integration of mental functions such as attention, memory, producing and understanding language and communication, learning, reasoning, problem solving, and decision making in order to process an adaptive behavioralRead MoreThomas Hardin And Julian L. Simon s The Tragedy Of The Commons935 Words à |à 4 Pagesin the worldââ¬â¢s population. Many viewpoints on this debate exist, and two views in particular contradict each other. These viewpoints include those of Garret Hardin and Julian L. Simon. Hardinââ¬â¢s view is expressed in ââ¬Å"The Tragedy of the Commons,â⬠and Simonââ¬â¢s in ââ¬Å"More People, Greater Wealth, More Resources, Healthier Environment.â⬠These debate problems and solutions of the growing population, including the use of natural resources in order to supply the worldââ¬â¢s growing population. Hardin perceivesRead MoreThe Problem Of A World Problem1281 Words à |à 6 PagesA world problem is one that cannot be solved by countries acting alone and do not affect one country alone, these problems will have consequences for many people across the globe. Additionally, global problems can be so significant that they affect the ability of the planet itself to support life. There are many world problems that are evident around the globe today, however the most significant problem is population growth. According to the UN News Centre, in 2015 the world population was 7.3Read MoreEssay Food Secuirty and Malnutition in the World829 Words à |à 4 PagesThe growing population of over seven billion has caused many people to worry about food security and malnutrition. Currently, there is enough food to feed everyone in the world but equal distribution is a major problem. However, with the growing population food security will become an increasingly significant problem because there will not be enough food for everyone. Likewise, as more countries are starting to develop, their dietary need and demand for better food increases. Developing countriesRead MoreThe Problem Of Rapid Population Growth1605 Words à |à 7 Pagesof time until 1804 to reach a world population of one billion people. Population statistics show that there were 1.6 billion people in 1900 and this figure reached 6 billion before the end of the 20th century. Over the past several decades, the world s population has be en growing exponentially. According to the population statistics, this figure is going to ascend to more than 9 billion people by the end of 2050. Recent studies shows that the growth rate of population has somewhat steadied from theRead MoreEssay On Overpopulation1683 Words à |à 7 Pagesexplore some of the problems associated with a rapidly growing population leading to overpopulation, such as an increase in hunger, a loss of land, and a loss of resources received from the land. We will discuss when the problem began and the history of how fast the worldââ¬â¢s population has multiplied from the lack of contraception assistance due to cost or availability; consequently, resulting in the overpopulation problem. Furthermore, I will purpose the righting of these problems will contribute toRead MoreProblems Associated With The Overpopulation Problem1553 Words à |à 7 Pagesthe problems associated with a rapidly growing population leading to overpopulation, such as an increase in hunger, a loss of land, and a loss of resources received from the land. I will discuss when the problem began and the history of how fast the worldââ¬â¢s population has multiplied from the lack of contraception assistance due to cost or availability, consequently, resulting in the overpopulation problem. Additionally, I will discuss who and what are affected by the overpopulation problem. FurthermoreRead MoreThe Problems Of The World s Population1606 Words à |à 7 PagesThe worldââ¬â¢s population has been increasing since the industrial revolution at a pace that has never been seen in human history, and with that growth comes the societal obligation of maintaining stable societies where everyone s basic needs are met. Among the most important of these needs is the drastically increasing demand to feed everyone. But just as technology sparked the industrial revolution that initially caused this problem, it has also been responsible for the innovative solutions weââ¬â ¢veRead MoreOverpopulation and Environmental Problems1008 Words à |à 5 PagesOverpopulation is becoming a leading environmental problem in which resources are becoming depleted faster than are being created. Hoevel explains, ââ¬Å"Overpopulation occurs when a populationââ¬â¢s density exceeds the capacity of the environment to supply the health requirements of an individualâ⬠(Hoevel 1). This means that after a population has overused the resources in an area, the environment will no longer be able to support them, and there lies the problem with overpopulation. Wenner explains, ââ¬Å"SustainabilityRead MoreOverpopulation : We Must Figure It Out For Save The World Essay1645 Words à |à 7 Pages Overpopulation: We Must Figure It Out to Save the World It may not be something you think about often, but human population growth is a big issue in our world today and this problem needs to be solved in the future to save our planet. Overpopulation is a condition that will be in effect if the population exceeds the carrying capacity on Earth. The carrying capacity is the peak population that can sustain human life on Earth. It is uncertain what Earthââ¬â¢s carrying capacity is for the human race
Term Paper Writers
<h1>Term Paper Writers</h1><p>A research paper author ought to compose for both the understudy and the educator. All things considered, the research paper ought to be intended to be a thorough investigation of the subject that is being talked about in class.</p><p></p><p>For this explanation, it's significant that the essayist can make all the focuses that are secured on the paper sound just as they're a characteristic piece of the conversation. Instructors are commonly amazing adjudicators of the nature of any paper they've at any point perused. What's more, since the topic isn't especially dry, it's essential to make a progression of thought wherein each point in the paper feels like it's incorporated naturally.</p><p></p><p>If you are thinking about composing a research project, a research paper essayist ought to have the option to get this cultivated. This isn't a zone that you ought to depend on any other person t o do.</p><p></p><p>First, you're attempting to pass on the thoughts that the essayist is advancing, not simply the assessments of the author. The word 'clear' is regularly used to portray this sort of composing. You need the peruser to 'see' what's going on. This is finished by giving setting, just as references and other verification that will assist with clarifying the thoughts in the paper.</p><p></p><p>Second, the paper is bound to be done when it is designed accurately. For instance, passages ought not be longer than one page, spelling mistakes and linguistic blunders ought to be maintained a strategic distance from, and such a large number of overabundance sections ought to be avoided.</p><p></p><p>Finally, the research project author ought to have the option to transform a work of scholastic piece into a reasonable, fresh, and elegantly composed synopsis. The rundown can be utilized as the central matter of the paper, or it very well may be utilized to integrate the thoughts in an intelligent manner. You may likewise need to incorporate a couple of informative supplements to finish the paper.</p><p></p><p>The commentator ought to have the option to utilize the rundown as a survey of the paper. It can mention to the analyst what points were shrouded in the paper, what ends were reached, and even give them recommendations on the most proficient method to improve their own work. At last, the rundown ought to have a record, so the analyst can catch up the thoughts in the paper.</p><p></p><p>That's the reason a research project essayist is actually quite significant. With a decent author on your side, the paper ought to be elegantly composed and simple to peruse. Composing a research project without one can prompt major frustration.</p>
Friday, May 8, 2020
Modes of Essay Writing
Modes of Essay WritingThere are four modes of essay writing, and each mode corresponds to a standard range of grade. The four modes are - Length; Introduction; Character Analysis; and Discussion. Length is a combination of thoughts, ideas, paragraphs, examples, ideas, or arguments that demonstrate the concepts and reasoning. Introduction is an introduction to a topic and Character Analysis is an analysis of a character or person in a situation.Length generally involves topics about which students have strong opinions. Length essays often use argumentation and describe the subject in a concise way. Introduction, on the other hand, involves using a research-based approach to examine a situation and this format presents facts and figures. Discussion essay concerns itself with the details and provides an overview. It presents information and findings in a clear and concise manner. Examples of each mode are given below.Essay length is an aspect of essay writing that needs some careful con sideration. Students who fail to establish clear rules about essay length may end up with a work that lacks structure and flows well. Too long of a piece is boring, so students who use the three modes below are recommended to set lengths accordingly.Essay length is a factor that should be considered carefully. Writers who use the three modes of essay writing are recommended to follow these guidelines. After gathering information and forming opinions, include substantial details of supporting information. Include supporting details that support the points in the essay. Find a middle ground between brevity and depth.Essay length is a key factor in establishing a writing style. This is an important part of proper writing and a student should aim for the best possible balance. When writing, you want to add meaning and interesting details to each paragraph to create a reader.Essay length is important when establishing a paragraph introduction. Length can vary, but the rule of thumb is ab out five or fewer sentences per paragraph. Essays should be readable and straightforward, so always keep the sentence count down to the bare minimum. In addition, keep each paragraph short and focused.Essay length should also be considered when developing a conclusion. Adding more detail in the conclusion will make the essay longer. The key is to keep the essay short and easy to read. A short and crisp conclusion is far easier to read than an overly wordy or broad conclusion. Remember, one goal of writing is to help a reader understand and learn something.Using the four modes of essay writing is simple. Set the essay length, then write a short and clear introduction and conclusion. Including supporting details will help students keep their essay moving along.
A Comprehensive Guide to the Term Paper Writing Service
A Comprehensive Guide to the Term Paper Writing ServiceTerm paper writing service in Canada is provided for students in most of the provinces and territories. It is important to note that the students use this service not for making any judgment on their studies but only for making certain to write a term paper on a certain topic. There are many advantages of using the term paper writing service.First, students who get the help of term paper writing service in Canada will be able to focus on their studies. The student has to find some time to himself and get a sufficient amount of work done. He does not have to waste time trying to check out what other papers are being written by others and find the correct papers. He can concentrate on his own task without having to be worried about whether he is doing the right job.Another advantage of writing term paper with help of term paper writing service in Canada is that he can read over the papers he is going to write himself and be sure th at the assignment is on point. This is because in case of writing his own papers, he can try to make corrections on them but with help of these services, he can ensure that the quality of papers he is writing is high.Students, especially those who are planning to get into the professional field, might not be able to write the best paper in the world. This is because he might be using some of the words that are not legal in the business field. As long as he has the term paper writing service in Canada to check out the content, he can ensure that the paper he is writing is legal and to the point.In case of getting the term paper writing service in Canada, the student has the option of looking through the comments and reviews posted by the clients of this service. This will give him a good idea of how much he is doing in terms of the content and style of writing that he is following. The cost of term paper writing service in Canada is quite reasonable. The fees charged vary from one co mpany to another but they are not exorbitant. It is important to note that in case of getting the term paper writing service in Canada, the price is not fixed.These are just a few of the advantages that students can derive from term paper writing service in Canada. There are many more benefits that will only be revealed if the student is able to check out the services before choosing the company.
Wednesday, May 6, 2020
Southwestââ¬â¢s Competititve Advantage Free Essays
STRATEGY IMPLEMENTATION AND MEASUREMENT METRICS ASSIGNMENT-1 SOUTHWEST AIRLINES CASE STUDY QUESTIONS 1. How does Southwest Airlines get its competitive advantage? 2. How does Southwest Airlines execute its strategy? 1. We will write a custom essay sample on Southwestââ¬â¢s Competititve Advantage or any similar topic only for you Order Now How does Southwest Airlines get its competitive advantage? Southwest Airlines uses a Cost Leadership Strategy, however most pricing strategists would agree that having a low price does not, in itself, constitute a competitive advantage. In fact, thinking that low prices are always a good strategy for competition is deeply misguided. However, at times, targeting low prices can lead to a strategic focus which delivers tremendous results. Modern competitive strategy will often examine firms from a resource-based view. According to this lens, competitive advantage derives from leveraging an inimitable resource to deliver value at a lower cost than the competitors. Price is a completely imitable resource. Any company can match the prices of its competitor if it so chooses. Hence, arguing that a low price is a strategic resource, or that it leads to a competitive advantage in and of itself, is illogical. Southwest Airlines has used the target pricing and utilized a marketing orientation since its infancy in 1971, even though these concepts were not fully defined back then. First, starting with the customers and the value they sought, Southwest Airlines initial target was customers traveling between cities in Texas, specifically between Dallas and Houston, Dallas and San Antonio, San Antonio and Houston. While Texas is larger than many countries, it isnââ¬â¢t so large that people canââ¬â¢t drive from city to city. Hence initially, the most comparable alternative to Southwest, and therefore its prime competition, wasnââ¬â¢t other airlines. Instead, it was the car. In uncovering the car as the competing alternative, Southwest was able to also identify the target price of its offering. Second, to compete with the car, Southwest Airlines had to price their service relatively similar to the cost of car travel. With this target in mind, they chose $20. While $20 is lower than the government allowable tax deduction for travel, it is also significantly higher than the price of gas alone to drive between these cities. Thus, at this $20 price, Southwest Airlines could be confident that it would capture many of the travelers that would have driven and convert them into short-hop air travelers. Third, the product was redefined to serve customers at this low price profitably. Consider what was removed from air travel and what was included instead. The table below enumerates the key points Points 1 Removed Reduced reservations flexibility: Reservations primarily made directly Southwest Airlines as they eschewed working with travel agents. No connections between airlines: Southwest Airlines would not transfer baggage between flights. Included or Added Simplicity in Pricing: Flat rate of $20 per leg of the journey. Also reduced the cost of price management, as no yield management system was needed initially. Higher convenience in terms of on-time arrivals: With a simplified fight route between lesser used airports, Southwest was able to operate more reliably. Higher convenience in flight frequency: With point to point flights, Southwest could offer service between Houston and Dallas with the same plane roughly every 2. hours. 2 3 No long-haul flights: Southwest Airlines customers could only take Southwest between a city-pair, not across the country or even across state lines initially. This greatly reduced cost of compliance with CAB rulings, as Southwestââ¬â¢s operations were not subject to interstate commerce rulings. 4 No in-flight meals: Southwest Airlines only offered peanuts and beverages. Fun: Friendly flight attendants provided jokes, costumes, and made flying comfortable with warm and caring service. Faster boarding times leading to faster flight turnarounds. More seats: With one class of service, Southwest Airlines could put 137 seats in a 737 versus 128 in a United Airlines 737. 5 6 No seat assignments: First come, first seated. No first class: One-class service. 7 Does not fly into major airports: or uses Use of underutilized airports that are less major airports concentrates on point close to metropolitan cities: reduced to point connections costs, punctuality Use of multiple aircraft types Frequent flyer program does not use miles earned Uses fuel efficient 737s: reduces maintenance and training costs Based on number of trips flown: reduced operating costs 9 From this list, we see a number of items which an airline would usually use to define superior value removed from Southwest Airlines offer. A Southwest customer couldnââ¬â¢t be treated to first class, couldnââ¬â¢t get food, couldnââ¬â¢t book them as part of a larger trip, couldnââ¬â¢t book with them through an agent, and couldnââ¬â¢t even preselect their seat. All of these features were exactly what defined a competitive airline at the time. And, all of these features added cost. Instead, Southwest Airlines selected a specific target customer ââ¬â a Texan traveling between cities in Texas ââ¬â and then determined what it would take to satisfy that customer. ? ? ? That customer was far more interested in travel efficiency than travel class. That customer would be glad to forgo a meal, especially in exchange for a friendly flight attendant and a Dr. Pepper. That customer was trading off driving for flying, and needed flexibility in booking rather than navigating through the decisions and planning related to yield management. This service described does not meet the wants of every customer that could have flown Southwest Airlines, but it does describe those of the target customer. And, given the choice of mediocrely satisfying everyone at a high cost or highly satisfying a select few at a low but profitable price, Southwest Airlines rightly chose the latter. As a result of tightly defining the value sought by customers (efficient and flexible travel), and the price ($20), Southwest was able to meet the needs and surpass the expectations of their target customer. Moreover, it was able to do this at a significantly lower cost than a standard airline. So can low prices deliver a competitive advantage? NO, not alone. But target pricing, where the price and benefits demanded by customer leads to a strategic focus that drives a redefinition of the product and service, can deliver a winning competitive advantage. One where a customer need is met at a cost below the price the target market is willing to pay. BALANCED SCORECARD FOR SWA 2. How does Southwest Airlines execute its strategy? Southwest Airlines is probably one of the most striking examples of a company that (a) Defined a very clear and simple key business purpose, (b) Chose the right business model to support the business purpose, and (c) Consistently demonstrates the core values and behaviors derived from that key business purpose. The brand promise of Southwest Airlines is: ââ¬ËDedication to the highest quality of Customer Service delivered with a sense of warmth, friendliness, individual pride, and Company Spiritââ¬â¢. Every single employee of the company is aligned with this brand promise and in spite of the current economic turmoil in the airline industrySouthwestââ¬â¢s performance isamong the best in the industry. Staff morale is exceptionally high. In 1971, Rollin King and Herb Kelleher started an airline service with one simple notion: ââ¬Å"If you get your passengers to their destinations when they want to get there, on time, at the lowest possible fares, and make darn sure they have a good time doing it, people will fly your airlineâ⬠. Southwest currently has the lowest operating-cost structure in the US domestic airline industry and consistently offers the lowest and most of all simplest fares. Southwest holds the best cumulative customer satisfaction record for the past 18 years. In December 2008, the airline had 35,499 employees and generated total operating revenues of $11 billion (2007 = $ 9. 8 billion, 2001 = $ 5. 3 billion) from a passenger load factor of 71. 2% with a fleet of 537 Boeing 737ââ¬â¢s. Its stock exchange symbol is ââ¬ËLUVââ¬â¢, representing Southwestââ¬â¢s home at Dallas Love Field, as well as the theme of its employee and customer relationships. The major success to their continued success seems due to their low-cost model and competitors being aware that they cannot match Southwest Airlinesââ¬â¢ low prices. Southwest Airlines has the reputation of being able to force a competitor into bankruptcy. It is believed, however, that it was not just the choice of its business model that made Southwest Airlines such a successful company; it is the way they execute their business model through perfect strategic alignment. Southwest Airlines succeeded in defining a very simple yet clear key business purpose; the fact that they aim for being ââ¬Å"the only short haul, low fare, high frequency, point-to-point carrier in Americaâ⬠leaves very little room for interpretation. What makes Southwest Airlinesââ¬â¢ key business purpose such a powerful one however, is not just the very clear definition of their ââ¬Ëraison dââ¬â¢ etreââ¬â¢, but certainly also what the company and its leaders do with it. Their simple but effective key business purpose is the main guiding principle for Southwest Airlinesââ¬â¢ strategic goals, business strategy, organizational infrastructure, and last ââ¬â but certainly not least ââ¬â their company culture. The organization of Southwest Airlines is best described as an upside-down pyramid ââ¬â an organization very much in line with the way they want to do business. The upper management is at the bottom and supports the front line employees, who are the experts. Front line employees play a major role in the yearly business planning and operational budget which for a great part is done bottom-up rather than top-down. This is the fruit of co-founder Herb Kelleherââ¬â¢s unorthodox leadership style, in which management decisions are made by everyone in the organization, not just the head executives. The company does not put much emphasis on structure; instead, employees are encouraged to think freely without constraints such as titles or official mandates. The reason for Southwest Airlineââ¬â¢s success is due to their clear key business purpose and core values, and due to the way in hich they consistently execute their business model (a combination of ââ¬Ëdisruptive innovationââ¬â¢ and ââ¬Ëcustomer intimacyââ¬â¢) in line with their key business purpose and core values. ? ? ? The Southwest Airlines fleet consists solely of Boeing 737s It offers only economy seats (there is no business or first class). Southwest Airlines also do not offer in-flight meals, only peanuts and other snacks. Southwest is simple and direct at the goal of their service; ââ¬Å"A primarily short-haul airline that flies directly from city to city, with just one type of plane ââ¬â the Boeing 737 ââ¬â and the lowest costsâ⬠. With a simple goal, Southwest has excised many of the ââ¬Ëluxuriesââ¬â¢ that competitors offer, such as luxury seats; this is made evident by their decision to enforce a rule for passengers who cannot fit into the seats to purchase an additional seat. This rather unpopular move ââ¬â whereas other airlines would have suggested a more luxury class seat ââ¬â is simple in its purpose ââ¬â get passengers from point A to point B with a minimum of frills, but with a friendly smile and great personal service. While Southwest Airlines offer no frills, they do meet and exceed customer expectations when it comes to personal service. They base their model on the motto ââ¬Å"If employees are happy, satisfied, dedicated, and energetic, theyââ¬â¢ll take real good care of the customers. When the customers are happy, they come back. And that makes the shareholders happyâ⬠. Southwest invests in very good relations with all their employees. Employees are either of independent labor unions or have flexible contracts which allow employees to work longer hours (adapting the business model to the key business purpose) How to cite Southwestââ¬â¢s Competititve Advantage, Essay examples
Wednesday, April 29, 2020
Marine Organisms and Other Novel Natural Sources of New Cancer Drugs Essay Example
Marine Organisms and Other Novel Natural Sources of New Cancer Drugs Essay Gilberto Schwartsmann South-American Office for Anticancer Drug Development (SOAD), Comprehensive Cancer Centre (CINCAN), The Lutheran University (ULBRA) Postgraduate Course in Medicine (UFRGS), Porto Alegre, Brazil Introduction Man has always relied on nature for survival. Since ancient times, nature has been our main source of food, protection, clothing, transportation and remedies [1,2]. This can be illustrated by the number of natural product derived agents currently in use in routine medical practice (Table 1) [3-5]. In addition o plant-derived compounds, microorganisms constitute a very important source of novel bioactive agents. They have contributed to the medical armamentarium with antibiotics such as penicillins, aminoglycosides and cephalosporins, which represent landmarks in the history of human therapeutics [6,7]. Although marine compounds are yet underrepresented in routine clinical practice, it can be anticipated that aquatic environment may become a potentially valua ble source of novel compounds, as the worlds oceans cover about 70% of the earths surface and all except 2 of the 28 major animal phyla are represented there [8-11]. Anti-cancer agents derived from natural sources Several new anticancer agents that entered the market in the 1990s were obtained from natural sources (Table 2) [12,13]. There is also a significant number of naturally derived new anticancer candidate compounds that are currently undergoing preclinical and early clinical development (Table 3) [3,14]. Plant-derived compounds, in particular, have . a special place in the anticancer therapy (Table 4) [15,16]. The Vinca alkaloid vincristine (isolated from Catharanthus roseus) is part of various curative regimens in patients with leukaemia and lymphoma [17,18]. Similarly, the epipodophyllotoxin derivative, etoposide (extracted from the mandrake plant Podophyllum peltatum and the wild chervill P. emodi) is included in drug regimens that produce a significant number of cures in patients with germ-cell tumours [19,20]. The taxoids (extracted from the bark of the Taxaceae Taxus brevifolia, T. canadensis, or T. baccata) and the camptothecins (derived from the bark and wood of the Nyssacea Camptotheca acuminata) have also significant anti-solid tumour Table 1 Drugs developed from plant sources Drug Medical use Plant source Aspirin Atropine Benzoin Caffeine Codeine We will write a custom essay sample on Marine Organisms and Other Novel Natural Sources of New Cancer Drugs specifically for you for only $16.38 $13.9/page Order now We will write a custom essay sample on Marine Organisms and Other Novel Natural Sources of New Cancer Drugs specifically for you FOR ONLY $16.38 $13.9/page Hire Writer We will write a custom essay sample on Marine Organisms and Other Novel Natural Sources of New Cancer Drugs specifically for you FOR ONLY $16.38 $13.9/page Hire Writer Digoxin Eugenol Hygoscyamine Morphine Papaverine Pilocarpine Quinine Reserpine Scopolamine Toxiferine Xanthotoxin Analgpsir, antiinflammatnry Pupil dilator Oral disinfectant Stimulant Analgesic, antitussive For atrial fibrillation and CHF For toothache Anticholinergic Analgesic Antispasmodic For glaucoma For malaria prophylaxis Antihypertensive For motion sickness Relaxant in surgery For vitiligo Filipendula ulmaria Atropa belladonna Sty rax tonkinensis Camellia sinensis Papaver somniferum Digitalis purpura Syzigium aromaticum Hyoscyamus niger Papaver somniferum Papaver somniferum Pilocarpus jaborandi Cinchona pubescens Rauwolfia serpentia Datura stramonium Strychnos guianensis Ammi majus 235 Downloaded from annonc. oxfordjournals. org by guest on December 7, 2010 236 G. Schwartsmann Table 2 Anticancer drugs developed from plant sources Drug Medical use Plant source Etoposide Testicular tumours, small cell lung cancer Teniposide Paediatric acute lymphoblastic leukaemia Vinblastine Hodgkins disease, non-Hodgkins lymphoma, carcinoma of the testis, Kaposis sarcoma, choriocarcinoma, breast cancer Vincristine Acute leukemia, Hodgkins disease, non-Hodgkins lymphoma, rhabdomyosarcoma, Wilms tumour Vindesine Investigational; modest activity in Hodgkins disease, non-Hodgkins lymphoma, leukaemias, non-small cell lung cancer, and breast cancer Vinorelbine Activity in breast and non-small cell lung cancer Paclitaxel Ovarian, breast, lung cancer and others Docetaxel Ovarian, breast, and lung cancers Topotecan Ovarian cancer Irinotecan Colorectal cancer Podophyllum peltatum and P. emodi Podophyllum pellatum and P. emodi Catharanthus roseus Catharanthus roseus Catharanthus roseus Catharanthus roseus Taxus brevifolia Taxus baccata Camptotheca acuminata Camptotheca acuminata Table 3 Examples of natural product derived agents approved for marketing (1990-1999) Bisantrene Interferon y-lA Cytarabine ocphosphate Miltefosine Porfimer sodium Pegaspargase Zinostatin stimalamer Gemcitabine Topotecan Irinotecan Fludarabine phosphate Pentostatin Formes tane Paclitaxel Sobuzoxane Bicalutamide Raltitrexed Docetaxel Lyposomal doxorubicin Lyposomal daunomycin Etoposide phosphate The agents are either natural products, semisynthetic analogues or the pharmacophore is from a natural product. From Cragg and Newman, 1999 [3]. activity [21]. Paclitaxel was approved by the FDA for the treatment of ovarian and breast carcinoma, nd has also important activity against other tumours such as non-small cell lung cancer [22]. Irinotecan and topotecan are more water-soluble semi-synthetic camptothecin derivatives which were approved for the treament of advanced colorectal [23,24], and ovarian carcinoma [25-27], respectively. These agents have also shown clinical antitumour activity in other malignancies of the adult and children [27]. Antitumour antibiotics such as doxorubicin, daunomycin, bleomycin, mitomycin, streptozocin and deoxycoformycin are clinically active agents against several types of cancers [28,29]. They were all isolated rom Streptomyces species. Other microbe-derived metabolites under current development are rhizoxin, deoxyspergualin, UCN-01 (7-hydroxystaurosporin), spicamycin (KRN5500), CC-1065 (bizelesin), and the rebeccamycin analogues [3,30,31]. The epithilone derivatives obtained from myxobacteria have gained Table 4 NCI-sponsored experimental agents whose pharmacophores are obtained from natural sources Source Agent Status Animal Animal Animal Marine Marine Microbial Microbial Microbial Microbial Microbial Microbial Microbial Microbial Microbial Microbial Microbial Microbial Microbial Microbial Plant Plant Plant Pyrimidine base Hydroxydopamine derivative Tributyrin 2-Methoxyestradiol derivative Halichondrin B Dolastatin 10 COL 3 Cordycepin/deoxycoformycin Geldanamycin derivative Iododoxorubicin Rapamycin derivative Vicenistatin Bizelesin Depsipeptide KRN55O0 9-cir-Retinoic acid Quinocarmycin derivative Rebeccamycin derivative Rhizoxin UCN-01 Neriifolin Flavopiridol Perllyl alcohol 5-Ethynyluracyl Preclinical PrecUnical Preclinical Preclinical * Clinical Preclinical Preclinical Preclinical Clinical Preclinical Preclinical Clinical Clinical Clinical Clinical Clinical Clinical Clinical Clinical PrecUnical Clinical Clinical Clinical From Cragg and Newman, 1999 [3]. also attention in the laboratory, because of the similarity of their mechanism of action to the taxoids [32]. Cytosine arabinoside, a synthetic analogue of the C-nuclesides initially isolated from the Caribbean sponge, Cryptotheca cripta, was the first and, so far, only, marine-derived compound routinely used in cancer therapy. It has significant antitumour activity in leukaemias and lymphomas [33,34]. The systematic exploration of marine organisms as sources of novel bioactive agents initiated in the 1970s and Downloaded from annonc. oxfordjournals. rg by guest on December 7, 2010 Marine organisms and other novel natural sources of new cancer drugs 237 expanded markedly since the mid-1980s. Presently, more than 2500 new metabolites were described from a variety of marine sources, anticipating its future role as a valuable source of novel chemical classes not usually found in the terrestrial environment [35-37]. Several potentially i nteresting marine compounds are in preclinical development. Discodermolide, a metabolite of the deep-sea sponge Discodermia dissolute, was collected in the waters of the Bahamas, and it was shown to induce microtubule stabilisation [35]. Halichondrin B, first isolated from the sponge Halichondria okadai in Japan has shown in vivo activity against melanoma and leukaemia. It is being currently obtained from the New Zealand deep-water sponge Lissodendoryx. Isogranulatimide, an aromatic alkaloid extracted from the Brazilian tunicate, ascidian Didemnum granulation, acts as a G2 checkpoint inhibitor. Its synthesis has been fully accomplished and several analogues are being developed [36]. Experimental anticancer agents in phase Iââ¬âII trials Tunicate derivatives Of the marine compounds that have entered clinical evaluation, three ââ¬â didemnin B (DB), aplidine DDB) and ecteinascidin 743 (ET 743) ââ¬â are derived from tunicates. DB is a cyclic depsipeptide isolated from the tunicate Trididemnum solidum and was the first to enter phase I and II studies. In phase II trials sponsored by the NCI, partial and complete tumour responses were documented in patients with non-Hodgkins lymphoma. However, DB caused cardiot oxicity and was stopped in its further development. DB also produced significant nausea and vomiting, and isolated cases of hypersensitivity reactions [36-38]. Aplidine was obtained from a Mediterranean colonial tunicate, Aplidium albicans. It has a pyruvyl group replacing the lactyl group in DB and its synthesis has been achieved. It appears more active than DB in preclinical models and apparently not cardiotoxic. Aplidine entered clinical trials in 1999 both in Europe and in the US under the sponsorship of the Spanish company Pharma Mar. The ecteinascidins (Ets) are derived from the Caribbean tunicate Ecteinascidia turbinata. Following a period of supply problems, enough amounts of this compound could be obtained from aquaculture and synthesis. The derivative Ecteinascidin 743 (ET 743) showed promising activity in murine and human tur, II â⬠¢ o gt; = 0 à «A/V II I I Fig. 1. Chemical structure ET743. mour models, and is currently in early clinical development (Fig. 1) [39,40]. It is a tetrahydroisoquinoline alkaloid that alkylates selectively guanine N2 from the DNA minor groove, and this alkylation is reversed by DNA denaturation. Therefore, it differs from other DNA alkylating agents so far used in the clinic [40]. Dolastatins The dolastatins are cytotoxic peptides, which can be cyclic or linear, derived from the sea hare, Dolabella auricularia, a mollusc from the Indian Ocean. Dolastatin 10 and 15 are small peptides that were shown o interact with tubulin. Dolastatin 10 (NSC 376128) was selected for initial clinical development because of its more favourable preclinical profile (Fig. 2). It is extremely potent in vitro and it was shown to inhibit microtubule assembly, tubulin-dependent guanosine triphosphate (GTP) binding and inhibit vincristine and vinblastine binding to tubulin. It causes cells to accumula te in metaphase arrest and is modulated by the MDR gene product [41,42]. Dolastatin 10 has in vitro activity against several human leukaemia, lymphoma and solid tumour cell lines with IC50S between 0. 1 to 10 nM. It has documented ntitumour activity in various human solid tumour models, such as LOX#IMVI melanoma, OVCAR- 3 ovarian carcinoma and NCI-H522 NSCLC O CH3 OCH3O H3CO Fig. 2. Structure of dolastatin 10 (NSC 376128). Downloaded from annonc. oxfordjournals. org by guest on December 7, 2010 238 G. Schwartsmann Fig. 3. Structure of bryostatin-1 (NSC 339555). cell lines. In animal toxicology studies, myelosuppression was the dose-limiting toxicity. This agent is highly bound to plasma proteins and pharmacokinetic studies in animals showed a rapid degradation probably by hepatic metabolism [43,44]. This agent entered phase I trials as an i. v. olus injection every 3 weeks. The maximum tolerated dose (MTD) was 300 mg/m2 for heavily preteated patients, while 400 mg/m2 appears to be the MTD for minimally pre-treated patients. The dose-limiting toxicity (DLT) was myelosuppression, and local irritation and phlebitis, and mild peripheral neuropathy were also observed. Phase II trials are being ini tiated in breast, colon, lung, ovarian and prostate cancer, as well as lymphomas and leukaemias [45,46]. Bryostatins Bryostatin-1 (NSC 339555) is a macrocyclic natural lactone isolated from the marine Bryozoan, Bugula neritina (Fig. 3). It has shown both antitumour as ell as immunomodulatory effects [47,48]. It is a potent activator of the protein kinase C (PKC) family, lacking tumour-promoting activity and with antagonistic effects on tumour-promoting phorbol esters. This effect is probably related to down-regulation of PKC or by specific isoform activation. It also stimulates cytokine production, bone marrow progenitor cells and neutrophils [49-51]. In vitro, bryostatin-1 has cytotoxic activity against various leukaemia and solid tumour cell lines [50]. It has also in vivo antitumour activity in various murine models, including leukemia, lymphoma, ovarian cancer and melanoma. It was shown to enhance the antitumour effects of various anticancer agents, such as vincristine, cytosine arabinoside, cisplatin, melphalan, paclitaxel and others. These effects may be schedule-dependent [47,48,52]. This agent was studied in phase I trials at different infusion schedules. The recommended doses for phase II trials were 25-35 M-g/m2 when administered over one hour for three of every four weeks; 25 u. g/m2 given as a weekly 24 hour infusion. Myalgia was the DLT in all trials. Other toxicities were joint aches and a transient decrease in platelet counts [53,54]. Notably, partial responses were reported in atients with melanoma, ovarian cancer and NHL. Phase II trials of bryostatin-1 are being conducted at various infusion regimens in a large number of tumour types in both solid and haematological malignancies. In addition, phase I trials of brystatin-1 in combination with other agents, such as cisplatin, paclitaxel, fludarabine, vincristine, cytosine arabinoside and 2-C DA are also being conducted under the sponsorship of the US NCI [51,53,54]. MGI-114 MGI-114 (6-hydroxymethylacylfulvene; HMAF; NSC 683863) is a semisynthetic derivative of illudin S, a naturally occurring sesquiterpene obtained from he mushroom Omphalotus olearius, which exerts its cytotoxic effect following its rapid intracellular uptake, covalent binding to DNA, inhibition of DNA synthesis and induction of apoptosis (Fig. 4). Binding to non-DNA cellular components appears also important for cytotoxicity [55,56]. In preclinical models, this form of DNA damage is more difficult to be repaired and requires functional DNA helicase activity. MGI-114 has shown in vitro cytotoxic activity in various human tumours and also in paediatric tumours. In vivo studies in animals bearing human tumour xenografts have shown antitumour ctivity in MX-1 breast carcinoma, MV522 lung CHjOH HO Fig. 4. Structure of MGI-114 (NSC 683863). Downloaded from annonc. oxfordjournals. org by guest on December 7, 2 010 Marine organisms and other novel natural sources of new cancer drugs 239 adenocarcinoma, DU145 and PC-3 prostate, HT-29 colon carcinoma and HL60/MRI myeloid leukaemia. It is also active in mdrl/gpl70 and other chemotherapy- resistant tumours. In preclinical models, including paediatric tumour cell lines, its antitumour effects were shown to be synergistic with paclitaxel, topotecan, irinotecan and 5-fluorouracil [55,56]. In a phase I study of MGI-114 given as a 5-minute infusion daily for 5 days every 28 days, grade 3 thrombocytopenia and neutropenia, and reversible renal damage were documented at a dose of 14 mg/m2/day. Other toxicities were nausea and vomiting, fatigue, asthenia, local phlebitis, facial flushing, alopecia and mucositis. Maximum plasma concentrations of MGI-114 in the range of levels required for in vitro cytotoxicity were obtained in the patients [57]. Therefore, the recommended dose for phase II trials was 10. 6 mg/m2/day for 5 consecutive days every 4 weeks. The US NCI is currently sponsoring rials in various solid rumours. A phase I trial widi the above mentioned schedule is also being performed in solid paediatric malignancies. Flavopiridol Havopiridol (NSC 649890) is the first cytotoxic agent in clinical trials that targets cell cycle progression at either Gl or G2 via the inhibition of cyclindependent kinases (CDKs). It is a synthetic flavone derived from the plant alkaloid r ohitukine isolated from Amoora rohituka, and later from Dysoxylum binectariferum (Fig. 5) [58]. It blocks cell growth and causes apoptosis in various rumour cell lines. It binds ATP competitively at the nucleotide-binding ite of CDKs. The G2 arrest is caused by both direct inhibition of CDK1 and changes in the regulatory phosphorylation of CDK1. The Gl arrest appears to depend on the inhibition of CDK2 and CDK4. At higher doses, flavopiridol also inhibits protein kinase A and C [58,59]. It has in vitro antiproliferative activity with IC50s between 50-200 nmol/1, and has been shown to be synergistic with various anticancer drugs, such as cisplatin, paclitaxel, 5-fluorouracil, cytosine arabinoside and topotecan. For some agents, this effect was schedule dependent (paclitaxel and 5-fluorouracil) while not for others (cisplatin). In vivo antitumour activity was demonstrated in colon, prostate, lung, breast, ovary, gastric and renal carcinomas as well as glioma, melanoma and lymphoma [58,59]. Phase I trials of flavopiridol given as a 3-day continuous i. v. infusion every 14 days have been performed [60]. The DLT was a secretory-type diarrhoea, and fatigue, asthenia, anorexia, local tumour pain, and transient rise in bilirubin was also observed. Objective responses were documented in patients with renal, gastric and colon cancer, and with NHL. The recommended dose for phase II trials was 50 mg/m2/day x 3. The initial phase II trials will e conducted in patients with colorectal, prostate, NSCLC, and renal cell carcinoma, and in patients with non-Hodgkins lymphoma and chronic lymphocytic leukaemia. Combination studies with cisplatin or paclitaxel are also being initiated in patients with advanced solid tumours. CCI-779 CCI-779 [sirolimus 42-{3-hydroxy-2-(hydroxymethyl)- 2-methylpropanoate}; NSC 683864] is a solub le structural analogue of rapamycin (sirolimus), a macrolide antibiotic isolated from Streptomyces hygroscopicus. It causes cell cycle arrest at Gl through the inhibition of signalling pathways that produce inhibition of RNA translation. It has marked immunosuppressive effects by interacting with signal transduction pathways that are critical for normal T cell function as well as for tumour cells. CCI-779 binds to immunophilins, inhibiting their function [61,62]. Being more water soluble and more stable than rapamycin, CCI-779 was selected for preclinical and potential future clinical development. It inhibits key signal transduction pathways, such as those regulated by p70s6 kinase and phosphorylated heat- and acid-stable protein (PHAS-I). The above mentioned inhibitory effect interferes with cell-cycle progression through Gl [63]. Preclinical studies suggested hat tumours with deletion of the pl5/pl6 family of CDK inhibitors, such as melanoma, may be especially susceptible to CCI-779 [62,63]. Two schedules of CCI-779 administration are being evaluated in phase I trials, weekly and daily times five every 2 weeks. Phase II trials are being planned for breast, pancreas, colon, glioma, lymphoma, small-cell lung cancer a nd melanoma [64]. Fig. 5. Structure of flavopiridol (NSC 649890). Downloaded from annonc. oxfordjournals. org by guest on December 7, 2010 240 G. Schwartsmann H3CN D-V4I J ^CH-C1 NH â⬠¢Cv .. CHa 1 LAM O CH3 Fig. 6. Structure of depsipeptide (NSC 630176). Fig. 7. Structure of rebeccamycin analog (NSC 655649). Depsipeptide Depsipeptide (NSC 630176) is a biclyclic peptide isolated from a strain of Chromobacterium violaceum by Fujisawa Pharmaceutical Co. (Fig. 6). It decreases mRNA expression of the c-myc oncogene and inhibits the growth of Hd-ras-transformed NIH3T3 clonal cell line, Ras-1. It did not affect DNA synthesis but causes cell cycle arrest at G0/G1. More recently, it was demonstrated that it acts as an inhibitor of a histone deacetylase [65,66]. It possesses potent preclinical antitumour activity both in vitro and in vivo. In vitro, depsipeptide howed cytotoxic activity in various human solid tumour cell lines, such as NSCLC, stomach, breast and colon adenocarcinomas, with IC5Os of 0. 3-3. 2 ng/ml, and was less potent against cultured normal cells. This agent appears to be also a substrate for MDR P-glycoprotein. In vivo, it showed antitumour activity against various murine and human solid tumours (such as stomach, colon, brea st and melanoma models) [65-67]. Two phase I trials of depsipeptide are being conducted using a 4 hour i. v. infusion weekly and twice-weekly, respectively, every 21 days. NSC D655649 (rebeccamycin analogue) The rebeccamycin analogue (l,ll-dichloro-6-[2-A- iethylamino]-12,13-dihydro-12-(4-0-methyl-D-glucopyranosyl)- 5H-indolo[pyrrolo[3,4-c]carbazole-5,7- (6H)-dione; NSC D655649) is a synthetic antibiotic with the antitumour properties of its less water-soluble parent compound, rebeccamycin, which was isolated from the actinomycete strain Saccharothrix aewcolingenes found in the soil in Panama (Fig. 7). It causes an unwinding of supercoiled DNA without inducing single-strand or double-strand breaks and also inhibits topoisomerase II by limiting strandpassing ability. This compound showed in vivo antitumour activity against various murine models as ell as in human tumour xenografts, such as ESC LOX melanomas and in the ESC RXK-393 renal tumour models [68]. Currently, three phase I studies of NSC D655649 in adults and one phase I trial in children are being conducted. Two adult and one paediatric trial use a single i. v. infusion every 21 days. The MTD is 572 mg/m2 and the recommended dose for phase II is 500 mg/m2 in adults. In children, the recommended dose for phase II is 585 mg/m2. The DLT was local irritation and phlebitis at the injection site, but it became nausea and vomiting, myelosuppression (mainly neutropenia) after the use of a central i. v. ine. Hyponatremia and elevations of liver enzymes were also documented (ALT/AST). Phase I trials of a 5-daily i. v. dose every 21 days revealed similar toxicity profile and produced partial responses in ovarian, gastric and cholangiocarcinoma [69]. Conclusion Nature has given a major contribution to cancer therapy. It contributed with the introduction of several active agents that dramatically changed the natural history of many types of human cancers. This new wave of natural product d erived experimental agents is offering us the opportunity to evaluate not only totally new chemical classes of anticancer agents, ut also novel and potentially relevant mechanisms of action [73-75]. Marine compounds, for instance, can interfere with very relevant intracellular targets such as signal transduction, microtubule stabilisation or new forms of interaction with DNA. They can be extremely potent in culture, with IC50S in tumour cell lines in the nanogram range [76,77]. Probably they need potency and rapid penetration in cellular membranes to protect themselves efficiently in an aquatic environment that rapidly dilute their poisons. However, these compounds can be very toxic to normal tissues as well. We are witnessing that Downloaded from annonc. xfordjournals. org by guest on December 7, 2010 Marine organisms and other novel natural sources of new cancer drugs 241 phenomenon with marine compounds that entered clinical evaluation. The same holds true for other plant- and mi crobial-derived experimental agents. Therefore, the challenge of finding more selective anticancer agents with a more favourable therapeutic index still remains. The search for new natural product derived compounds for cancer treatment will continue through an active international collaboration among researchers in investigating rainforests, coral reefs and deep subsurface thermal vents [70-72]. These efforts are being expanded by recent advances in microbial cultivation technology and nucleic acid extraction from environmental materials. A large number of novel living organisms that provide a tremendously rich reservoir of genetic and metabolic diversity are being identified. Furthermore, manipulation of microbial biosynthetic pathways making use of genetic . engineering has allowed the production of interesting molecules not generated naturally [3,72,73,78]. These unique sources of novel compounds will certainly make anticancer drug discovery even more challenging in the next years. References Famsworth NR, Akerele O, Bingel AS, et al. Medicinal plants in therapy. Bull WHO 1985; 63: 965-981. 2 Cragg GM, Newman DJ, Snader KM, et al. Natural products in drug discovery and development J Nat Prod 1997; 60: 52-60. 3 Cragg GM, Newman DJ. Discovery and development of antineoplastic agents from natural sources. Cancer Invest 1999; 17(2): 153-163. 4 Balandrin MF, Kinghorn AD, Famsw orth NR. Plant-derived natural products in drug discovery and development: An overview. In: AD Kinghorn, MF Balandrin (eds), Human Medicinal Agents from Plants. Am Chem Soc Symposium Series 534. Am Chem Soc Washington, DC, 1993, pp 2-12. Farnsworth NR. The role of ethnopharmacology in drug development. CIBA Found Symp 1994; 154: 25-41. 6 Young P. Major microbial diversity initiative recommended. ASM News 1997; 63: 417-421. 7 Samuelsson G. Drugs of Natural Origin. Swedish Pharmaceutical Press, Stockholm, 1992. 8 Christian MC, Pluda JM, Ho TC, et al. Promising new agents under development by the Division of Cancer Treatment, Diagnosis and Centers of the National Cancer Institute. Semin Oncol 1997; 24: 219-240. 9 Rosenthal J. OECD Proceedings: Investing in biological diversity. The Cairns Conference, Australia, 25-28 March, 1996. OECD Publications, Paris, 1997, pp 253. 10 Suffness M, Cragg GM, Grever MR, et al. The National Cooperative Natural Products Drug Discovery Group (NCNPDDG) and International Cooperative Biodiversity Group (ICBG) Programs. Int J Phannacogn 1995; 33 (suppl): 5-16. 11 Bergmann W, Feeney R. Contributions to the study of marine products: XXXH. The nucleosides of sponges. J Org Chem 1951; 16: 981-987. 12 Famsworth NR. The role of medicinal plants in drug development In: P Krogsgaard-Larsen, SB Christensen, H Kofod (eds), Natural Products and Drug Development Balliere, Tindall, and Cox, London, 1984, pp 8-98. 13 Cox PA. The ethnobotanical approach to drug discovery: strengths and limitations. CIBA Found Symp 1994; 185: 2 5 41. 14 Hartwell JL. Plants used against cancer. A survey. Quartennan Publications, Lawrence, 1982. 15 Han R. Recent progress in the study of anticancer drugs originating from plants and traditional medicines in China. Chin Med Sci J 1994; 9: 61-69. 16 Chabner BA. Anticancer drugs (Chapter 18). In: VT DeVita Jr, S Hellman, AS Rosenberg (eds), Cancer: Principles and Practice, 4th edn. Lippincott, Philadelphia, 1991, pp 325-417. 17 Johnson IS, Armstrong JG, Gorman M, et al. The Vinca alkaloids: a new class of oncolytic agents. Cancer Res 1963; 23: 1390-1397. 18 DeVita VT Jr. Serpick AA, Carbone PO. Combination chemotherapy in the treatment of advanced Hodgkins disease. Ann Intern Med 1970; 73: 881-895. 19 Williams SD, Birch R, Einhom LH, et al. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 1987; 316: 1435-1440. 20 Wani MC, Taylor HL, Wall ME, et al. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia, J Am Chem Soc 1971; 93: 2325-2327. 21 Wall ME, Wani MC, Cook CE, et al. Plant anti-tumor agents: I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata. J Am Chem Soc 1966; 88: 3888-3890. 22 McGuire WP, Hoskins WJ, Brady MF, et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage IE and IV ovarian cancer. N Engl J Med 1996; 334: -6. 23 Bertino JR. Irinotecan for colorectal cancer. Semin Oncol 1997; 24: S18-S23. 24 Pito HC, Wender DB, OConnell MJ, et al. Phase JJ trial of irinotecan in patients with metastatic colorectal carcinoma. J Clin Oncol 1997; 15:2910-2919. 25 Creemers GJ, Bolis G, Gore M, et al. Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer. J Clin Oncol 1996; 14: 3056-3061. 26 Sikora K, Advani S, Koroltchouk V, et al. Essential drugs for cancer therapy: a World Health Organization consultation. Ann Oncol 1999; 10: 385-390. 27 Kunimoto T, Nitta K, Tanaka T, et al. Antitumor activity of 7-ethy 1-10-(4-( 1 -piperidino)-1 -piperidino)carbonyloxy-camptothecin, a novel water-soluble derivative of camptothecin, against murine tumors. Cancer Res 1987; 47: 5944-5947. 28 DiMarco A, Gaetani M, Scarpinato B. Adriamycin (NSC 123127) a new antibiotic with antitumor activity. Cancer Chemother Rep 1969; 53: 33-37. 29 Grever MR, Chabner BA. Cancer drug discovery and development (Section 1, Chapter 18). In: VT DeVita, S Hellman, SA Rosenberg (eds), Cancer Principles and Practice of Oncology, 5th edn. Lippincott-Raven, Philadelphia, 1997, pp 328-339. 30 Powis G. Anticancer drugs: antimetabolite metabolism and natural anticancer agents. Int Encycl Pharmacol Ther 1994; 140: 1-506. 31 Jessup JM, McGinnis LS, Winchester DP, et al. Clinical Downloaded from annonc. oxfordjournals. org by guest on December 7, 2010 242 G. Schwartsmann highlights from the National Cancer Database: 1996. CA Cancer J Clin 1996; 46: 185-187. 2 Bollag DM, McQueney PA, Zhu J, et al. Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action. Cancer Res 1995; 55: 2325-2333. 33 Cragg GM, Newman DJ and Weiss RB. Coral reefs, forests, and thermal vents: the worldwide exploration of nature for novel antitumor agents. Semin Oncol 1997; 24: 156-163. 34 Kitagawa I, K obayashi M. Antitumor marine natural products. Gan To Kagaku Ryoho 190; 17(3): 322-329. 35 Kowalski RJ, Giannakakou P, Gunasekera SP, et al. The microtubule- stabilizing agent discodermolide competitively inhibits the binding of paclitaxel to tubulin polymers, enhances ubuline nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells. Mol Pharmacol 1997; 52: 613-622. 36 Schmidt U, Griesser H, Hass G, et al. Synthesis and cytostatic activities of didemnin derivatives. J Peptide Res 1999; 54: 146-161. 37 Weiss RB, Peterson BL, Allen SL, et al. A phase II trial of didemnin B in myeloma. A cancer and leukemia group B (CALGB) study. Invest New Drugs 1994; 12(1): 41-43. 38 Chun HG, Davies B, Hoth D, et al. Didemnin B. The first marine compound entering clinical trials as an amineoplastic agent. Invest New Drugs 4(3): 279-284. 39 Rinehart KL. Antitumor compounds from tunicates. Med Res Ver 2000; 20(1): 1-27. 40 Takebayashi Y, Pommier Y. DNA minor groove alkylation by Ecteinascidin 743 indices sequence specific topoisomerase I-mediated DNA damage. Proc Am Assoc Cancer Res 1999; 40 (#718). 41 Pettit GR, et al. The isolation and structure of a remarkable marine animal amineoplastic constituent: Dolastatin 10. J Am Chem Sec 1987; 109: 6883-6885. 42 Bai R, Pettit GR, Hamel E. Dolastatin 10, a powerful cytostatic peptide derived from a marine animal. Inhibition of tubulin polymerization mediated through the vinca alkaloid binding domain. Biochem Pharmacol 1990; 39(12): 1941- 949. 43 Pathak S, Multani AS, Ozen M, et al. Dolastatin-10 induces polyploidy, telomeric associations and apoptosis in a murine melanoma cell line. Oncol Rep 1998; 5(2): 373-376. 44 Maki A, Mohammad R, Raza S, et al. Effect of dolastatin 10 on human non-Hodgkin lymphoma cell lines. Anticancer Drugs 1996; 7(3): 344-350. 45 Madden T, Tran HT, Huie R, et al. N ovel marine-derived anticancer agent: a phase I clinical, pharmacological and pharmacodynamic study of dolastatin 10 (NSC 376128) in patients with advanced solid tumors. Clin Cancer Res 2000; 6: 1293-1301. 46 McElroy EA, Pitot HC, Erlichman C, et al. Phase I trial of dolastatin-10 in patients with advanced solid tumors. Proc Am Soc Clin Oncol 1997; abstr. #782. 47 Wender PA, Hinkle KW, Koehler MF, Lippa B. The rational design of potential chemotherapeutic agents: synthesis of bryostatin analogues. Med Res Rev 1999; 19(5): 388-407. 48 Wall NR, Mohammed RM, Nabha SM, et al. Modulation of Ciap-1 by novel antitubulin agents when combined with bryostatin 1 results in increased apoptosis in human early pre-B acute lymphoblastic leukemia cell line REH. Biochem Biophys Res Commun 1999; 266: 76-80. 49 Trenn G, Pettit GR, Takayama H, et al. Immunomodulating roperties of a novel series of protein kinase C activators. The bryostatins
Friday, March 20, 2020
U.S. President Mckinley Assassinated
U.S. President Mckinley Assassinated On September 6, 1901, anarchist Leon Czolgosz walked up to U.S. President William McKinley at the Pan-American Exposition in New York and shot McKinley at point-blank range. After the shooting, it first appeared that President McKinley was getting better; however, he soon took a turn for the worse and died on September 14 from gangrene. The daylight assassination attempt horrified millions of Americans. Greeting People at the Pan-American Exposition On September 6, 1901, U.S. President William McKinley spent the morning visiting Niagara Falls with his wife before returning to the Pan-American Exposition in Buffalo, New York in the afternoon to spend a few minutes greeting the public. By about 3:30 p.m., President McKinley stood inside the Temple of Music building at the Exposition, ready to begin shaking the hands of the public as they streamed into the building. Many had been waiting for hours outside in the heat for their chance to meet the President. Unbeknownst to the President and the many guards who stood nearby, among those waiting outside was 28-year-old anarchist Leon Czolgosz who was planning to kill President McKinley. At 4 p.m. the doors to the building were opened and the mass of people waiting outside were forced into a single line as they entered the Temple of Music building. The line of people thus came up to the President in an organized fashion, with just enough time to whisper a Nice to meet you, Mr. President, shake President McKinleys hand, and then be forced to continue along the line and out the door again. President McKinley, the 25th president of the United States, was a popular president who had just started his second term in office and the people seemed clearly glad to get a chance to meet him. However, at 4:07 p.m. Leon Czolgosz had made it into the building and it was his turn to greet the President. Two Shots Rang Out In Czolgoszs right hand, he held a .32 caliber Iver-Johnson revolver, which he had covered by wrapping a handkerchief around the gun and his hand. Although Czolgoszs swaddled hand was noticed before he reached the President, many thought it looked like it covered an injury and not that it was hiding a gun. Also, since the day had been hot, many of the visitors to see the President had been carrying handkerchiefs in their hands so that they could wipe the sweat off their faces. When Czolgosz reached the President, President McKinley reached out to shake his left hand (thinking Czolgoszs right hand was injured) while Czolgosz brought up his right hand to President McKinleys chest and then fired two shots. One of the bullets didnt enter the president - some say it bounced off of a button or off the presidents sternum and then got tucked into his clothing. The other bullet, however, entered the presidents abdomen, tearing through his stomach, pancreas, and kidney. Shocked at being shot, President McKinley began to sag as blood stained his white shirt. He then told those around him, Be careful how you tell my wife. Those in line behind Czolgosz and guards in the room all jumped on Czolgosz and started to punch him. Seeing that the mob on Czolgosz might easily and quickly kill him, President McKinley whispered either, Dont let them hurt him or Go easy on him, boys. President McKinley Undergoes Surgery President McKinley was then whisked away in an electric ambulance to the hospital at the Exposition. Unfortunately, the hospital was not properly equipped for such a surgery and the very experienced doctor usually on premises was away doing a surgery in another town. Although several doctors were found, the most experienced doctor that could be found was Dr. Matthew Mann, a gynecologist. The surgery began at 5:20 p.m. During the operation, the doctors searched for the remains of the bullet that had entered the Presidents abdomen, but were unable to locate it. Worried that continued searching would tax the Presidents body too much, the doctors decided to discontinue looking for it and to sew up what they could. The surgery was completed a little before 7 p.m. Gangrene and Death For several days, President McKinley seemed to be getting better. After the shock of the shooting, the nation was excited to hear some good news. However, what the doctors did not realize was that without drainage, an infection had built up inside the President. By September 13 it was obvious the President was dying. At 2:15 a.m. on September 14, 1901, President William McKinley died of gangrene. That afternoon, Vice President Theodore Roosevelt was sworn in as President of the United States. The Execution of Leon Czolgosz After being pummeled right after the shooting, Leon Czolgosz had been arrested and taken to police headquarters before nearly being lynched by the angry crowds that surrounded the Temple of Music. Czolgosz readily admitted that he was the one who had shot the President. In his written confession, Czolgosz stated, I killed President McKinley because I done my duty. I didnt believe one man should have so much service and another man should have none. Czolgosz was brought to trial on September 23, 1901. He was quickly found guilty and sentenced to death. On October 29, 1901, Leon Czolgosz was electrocuted.
Subscribe to:
Posts (Atom)